Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lin Shen, Professor
Peking University Cancer Hospital & Institute
Principal Investigator - Xianjun Yu, Professor
Fudan University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anhui Provincial Cancer Hospital
Hefei, Anhui, China
- Beijing Cancer Hospital
Beijing, Beijing Municipality, China
- Fujian Medical University Union Hospital
Fuzhou, Fujian, China
- Peking University Shenzhen Hospital
Shenzhen, Guangzhou, China
- Harbin Medical University Affiliated Cancer Hospital
Harbin, Heilongjia, China
- Henan Tumor Hospital
Zhengzhou, Henan, China
- the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, China
- Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
- the Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
- Northern Jiangsu People'S Hospital
Yangzhou, Jiangsu, China
- the Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
- the First Hospital of Jilin University
Changchun, Jilin, China
- the First Hospital of China Medical University
Shenyang, Liaoning, China
- Shandong Cancer Hospital
Jinan, Shandong, China
- the Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
- Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
- Ruijin Hospital, Affiliated To Shanghai Jiaotong University, School of Medicine
Shanghai, Shanghai Municipality, China
- Shanghai Zhongshan Hospital
Shanghai, Shanghai Municipality, China
- Sichuan Cancer Hospital
Chengdu, Sichuan, China
- West China Hospital, Sichuan University
Chengdu, Sichuan, China
- Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China
- the First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hanzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Oct 2020
- Primary completion
- 18 Oct 2024
- Completion
- 30 Jun 2038
- Last update posted
- 5 Jun 2025
- Registered enrollment
- 192
- Registry id
- NCT04581473
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.